走罐治疗斑块状银屑病的随机多中心临床试验方案
该研究为多中心、两臂平行、单盲、随机对照试验,计划在中国六家医院纳入122例18-65岁斑块状银屑病成人患者,比较基础治疗联合走罐与基础治疗联合走罐安慰剂。治疗周期4周,每周用PASI评估疗效,并在第6、8周随访,同时记录体表面积、PGA、DLQI、VAS、中医证候评分、合并用药及不良事件。
要点
- 走罐作为低成本中医疗法,拟在随机对照试验中评估其治疗斑块状银屑病的疗效与安全性。
- 主要疗效指标为PASI,治疗期每周评估,第6、8周随访。
- 次要指标包括BSA、PGA、DLQI、VAS、中医证候评分、合并用药和不良事件。
核心结论
- 该试验旨在评估走罐治疗斑块状银屑病的疗效与安全性,结果可能为临床决策提供依据。
研究设计与样本
- 多中心、两臂平行、单盲、随机对照试验,在中国六家医院开展,计划纳入122例18-65岁成人患者。
关键数值与推荐
- 治疗周期4周,每周用PASI评估疗效,第6、8周随访。
- 同时记录体表面积、PGA、DLQI、患者报告生活质量、VAS、中医证候评分、合并用药和不良事件。
临床怎么用
- 若试验结果有利,走罐可能因其简便低成本而值得推广用于斑块状银屑病治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is difficult to achieve a balance among safety, efficacy, and cost for the clinical treatment of plaque psoriasis. The current treatment of psoriasis often involves comprehensive therapy such as topical plasters, internal medicine, and phototherapy, which are expensive, and some of the drugs have serious side effects. Moving cupping is a type of cupping that has been used clinically for thousands of years in China. It has the advantage of being inexpensive and easy to perform. Therefore, it is widely used in public hospitals in China for psoriasis treatment. However, a comprehensive evaluation of the current clinical evidence of its efficacy is lacking. In this study, we aimed to evaluate the efficacy and safety of moving cupping to treat plaque psoriasis. METHODS: A multicenter, two-arm parallel group, single-blind, randomized, controlled trial will be conducted at six hospitals in China between August 1, 2019 and December 31, 2021. A total of 122 adult patients (aged 18-65 years) who meet the inclusion criteria are being recruited. Participants will receive either basic treatment combined with moving cupping therapy or basic treatment combined with moving cupping placebo. The treatment cycle will be 4 weeks, and the efficacy of treatment will be assessed weekly by the Psoriasis Area and Severity Index during the treatment period and follow-up visits at weeks 6 and 8. The body surface area, physician's global assessment, Dermatology Life Quality Index, patient-reported quality of life, visual analog scale, Traditional Chinese Medication syndrome scoring scale, combined medication, and adverse events will also be recorded and compared to the relative baseline values. DISCUSSION: The findings of this trial may lead to better decisions regarding the treatment of plaque psoriasis. If the trial outcomes are considered favorable, this ancient Chinese medical therapy may be worthy of widespread use because of its convenience and low cost. TRIAL REGISTRATION: This study was registered on May 15,2019 at ClinicalTrials.gov with the identifier number NCT03952676.
引用
- Xing M, Yan X, Yang S, et al. Effects of moving cupping therapy for plaque psoriasis: study protocol for a randomized multicenter clinical trial. Trials. 2020. PMID: 32102679. doi:10.1186/s13063-020-4155-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。